Glucagonlike-peptide-2 analogue enhances intestinal mucosal mass after ischemia and reperfusion

Journal of Pediatric Surgery

Volumn 35, Issue 2, 2000, Pages 357-359

  Prasad, Rajeev ^a   Alavi, Karim ^a   Schwartz, Marshall Z ^a  

^a NEMOURS ALFRED I DUPONT HOSPITAL FOR CHILDREN   (United States)

Author keywords

Glucagonlike peptide 2; Growth factor; Intesestinal mucosa; Ischemia and reperfusion injury

Indexed keywords

DNA; GLUCAGON LIKE PEPTIDE; PROGLUCAGON; PROTEIN;

ANIMAL MODEL; ANIMAL TISSUE; CONFERENCE PAPER; CONTROLLED STUDY; INTESTINE ISCHEMIA; INTESTINE MUCOSA; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; REPERFUSION INJURY;

EID: 0033964619     PISSN: 00223468     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-3468(00)90040-X     Document Type: Article

References (15)

1. Shah KA, Shurey S, Green CJ: Apoptosis after intestinal ischemia-reperfusion injury. Transplantation 64:1393-1397, 1997
2. Burton K: A study of the conditions and mechanisms of the diphenylamine reaction for the colorimetric estimation of deoxyribonucleic acid. Biochem J 62:315-323, 1956
3. Giles KW, Myers A: An improved diphenylamine method for the estimation of deoxyribonucleic acid. Nature 206:93, 1965
4. Lowry OH, Rosebrough NJ, Farr AL, et al: Protein measurement with the folin phenol reagent. J Biol Chem 193:265-275, 1951
5. Schmeling DJ, Caty MG, Oldham KT. et al: Cytoprotection by diclofenac sodium after intestinal ischemia/reperfusion injury. J Pediatr Surg 29:1044-1048, 1994
6. O'Donnell KA, Caty MG, Zheng S, et al: Oxygenated intraluminal perfluorocarbon protects intestinal mucosa from ischemia/ reperfusion injury. J Pediatr Surg 32:361-365, 1997
7. Pillai SB, Turman MA, Besner GE: Heparin-binding EGF-like growth factor is cytoprotective for intestinal epithelial cells exposed to hypoxia. J Pediatr Surg 33:973-978, 1998
8. Gleeson MH, Bloom SR, Polak JM, et al: Endocrine tumour in kidney affecting small bowel structure, motility, and absorptive function. Gut 12:773-782, 1971
9. Stevens FM, Flanagan RW, O'Gorman D, et al: Glucagonoma syndrome demonstrating giant duodenal villi. Gut 25:784-791, 1984
10. Drucker DJ, Ehrlich P, Asa SL, et al: Induction of intestinal epithelial proliferation by glucagon-like peptide 2. Proc Natl Acad Sci U S A 93:7911-7916, 1996
11. Brubaker PL, Izzo A, Hill M, et al: Intestinal function in mice with small bowel growth induced by glucagon-like peptide-2. Am J Physiol 272:E1050-E1058, 1997
12. Tsai C, Hill M, Asa SL, et al: Intestinal growth promoting properties of glucagon-like peptide-2 in mice. Am J Physiol 273:E77-E84, 1997
13. Fischer KD, Dhanvantari S, Drucker DJ, et al: Intestinal growth is associated with elevated levels of glucagon-like peptide 2 in diabetic rats. Am J Physiol 273:E815-E820, 1997
14. 2]glucagon-like peptide 2. Am J Physiol 273:G1252-G1262, 1997
15. Kato Y, Alavi K, Yu D, et al: Glucagon-like peptide-2 enhances intestinal function following massive small bowel resection. Gastroenterology 114:A1152, 1998